Extract from the Register of European Patents

EP About this file: EP3922197

EP3922197 - CONNECTION OF INTRAVASCULAR INTERVENTIONAL ELEMENTS AND ELONGATE MANIPULATION MEMBERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.02.2026
Database last updated on 14.03.2026
FormerThe patent has been granted
Status updated on  28.02.2025
FormerGrant of patent is intended
Status updated on  30.10.2024
FormerRequest for examination was made
Status updated on  13.05.2022
FormerThe application has been published
Status updated on  12.11.2021
Most recent event   Tooltip06.02.2026Lapse of the patent in a contracting state
New state(s): MC
published on 11.03.2026  [2026/11]
06.02.2026No opposition filed within time limitpublished on 11.03.2026  [2026/11]
Applicant(s)For all designated states
Covidien LP
15 Hampshire Street
Mansfield, MA 02048 / US
[2021/50]
Inventor(s)01 / SKILLRUD, Erik
Irvine, CA 92617 / US
02 / EPSTEIN, Evan D.
Irvine, CA 92617 / US
03 / CHEN, Lily
Irvine, CA 92617 / US
04 / GREGG, Chelsea L.
Irvine, CA 92617 / US
05 / DEEN, Daniel J.
Irvine, CA 92617 / US
 [2024/49]
Former [2024/45]01 / SKILLRUD, Erik
Irvine, CA 92617 / US
02 / EPSTEIN, Evan D
Irvine, CA 92617 / US
03 / CHEN, Lily
Irvine, CA 92617 / US
04 / GREGG, Chelsea L
Irvine, CA 92617 / US
05 / DEEN, Daniel J.
Irvine, CA 92617 / US
Former [2021/50]01 / SKILLRUD, Erik
Irvine CA 92617 / US
02 / EPSTEIN, Evan D
Irvine CA 92617 / US
03 / CHEN, Lily
Irvine CA 92617 / US
04 / GREGG, Chelsea L
Irvine CA 92617 / US
05 / DEEN, Daniel J.
Irvine CA 92617 / US
Representative(s)Gray, James
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[2021/50]
Application number, filing date21175555.824.05.2021
[2021/50]
Priority number, dateUS20201694614608.06.2020         Original published format: US202016946146
[2021/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3922197
Date:15.12.2021
Language:EN
[2021/50]
Type: B1 Patent specification 
No.:EP3922197
Date:02.04.2025
Language:EN
[2025/14]
Search report(s)(Supplementary) European search report - dispatched on:EP08.10.2021
ClassificationIPC:A61B17/221
[2021/50]
CPC:
A61B17/221 (EP); A61B17/22031 (CN); A61M39/10 (US);
A61M25/0021 (US); A61M25/007 (US); A61M25/0138 (US);
A61M39/0247 (US); A61B2017/22035 (CN); A61B2017/2215 (EP);
A61M2025/0042 (US); A61M2039/0258 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/24]
Former [2021/50]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERBINDUNG VON INTRAVASKULÄREN INTERVENTIONSELEMENTEN UND LÄNGLICHEN MANIPULATIONSELEMENTEN[2021/50]
English:CONNECTION OF INTRAVASCULAR INTERVENTIONAL ELEMENTS AND ELONGATE MANIPULATION MEMBERS[2021/50]
French:RACCORDEMENT D'ÉLÉMENTS D'INTERVENTION INTRAVASCULAIRE ET D'ÉLÉMENTS DE MANIPULATION ALLONGÉS[2021/50]
Examination procedure09.05.2022Amendment by applicant (claims and/or description)
10.05.2022Examination requested  [2022/24]
10.05.2022Date on which the examining division has become responsible
30.10.2024Communication of intention to grant the patent
21.02.2025Fee for grant paid
21.02.2025Fee for publishing/printing paid
21.02.2025Receipt of the translation of the claim(s)
Opposition(s)05.01.2026No opposition filed within time limit [2026/11]
Fees paidRenewal fee
23.05.2023Renewal fee patent year 03
21.05.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT02.04.2025
BG02.04.2025
CZ02.04.2025
DK02.04.2025
EE02.04.2025
ES02.04.2025
FI02.04.2025
HR02.04.2025
IT02.04.2025
LV02.04.2025
MC02.04.2025
NL02.04.2025
PL02.04.2025
RO02.04.2025
SK02.04.2025
SM02.04.2025
LU24.05.2025
CH31.05.2025
NO02.07.2025
RS02.07.2025
GR03.07.2025
IS02.08.2025
PT04.08.2025
[2026/11]
Former [2026/10]AT02.04.2025
BG02.04.2025
CZ02.04.2025
DK02.04.2025
EE02.04.2025
ES02.04.2025
FI02.04.2025
HR02.04.2025
IT02.04.2025
LV02.04.2025
NL02.04.2025
PL02.04.2025
RO02.04.2025
SK02.04.2025
SM02.04.2025
LU24.05.2025
CH31.05.2025
NO02.07.2025
RS02.07.2025
GR03.07.2025
IS02.08.2025
PT04.08.2025
Former [2026/09]AT02.04.2025
BG02.04.2025
CZ02.04.2025
DK02.04.2025
ES02.04.2025
FI02.04.2025
HR02.04.2025
LV02.04.2025
NL02.04.2025
PL02.04.2025
SM02.04.2025
LU24.05.2025
CH31.05.2025
NO02.07.2025
RS02.07.2025
GR03.07.2025
IS02.08.2025
PT04.08.2025
Former [2026/08]AT02.04.2025
BG02.04.2025
DK02.04.2025
ES02.04.2025
FI02.04.2025
HR02.04.2025
LV02.04.2025
NL02.04.2025
PL02.04.2025
SM02.04.2025
LU24.05.2025
NO02.07.2025
RS02.07.2025
GR03.07.2025
IS02.08.2025
PT04.08.2025
Former [2025/49]AT02.04.2025
BG02.04.2025
ES02.04.2025
FI02.04.2025
HR02.04.2025
LV02.04.2025
NL02.04.2025
PL02.04.2025
NO02.07.2025
RS02.07.2025
GR03.07.2025
IS02.08.2025
PT04.08.2025
Former [2025/48]AT02.04.2025
BG02.04.2025
ES02.04.2025
FI02.04.2025
HR02.04.2025
NL02.04.2025
PL02.04.2025
NO02.07.2025
RS02.07.2025
GR03.07.2025
PT04.08.2025
Former [2025/47]BG02.04.2025
ES02.04.2025
FI02.04.2025
NL02.04.2025
PL02.04.2025
NO02.07.2025
GR03.07.2025
PT04.08.2025
Former [2025/46]ES02.04.2025
FI02.04.2025
NL02.04.2025
PT04.08.2025
Former [2025/43]NL02.04.2025
Documents cited:Search[I] US2018325532  (SKILLRUD ERIK et al.)
 [A] US6059719  (YAMAMOTO TETSUYA et al.)
 [A] US2002010487  (EVANS MICHAEL A et al.)
 [A] EP3593742  (NEURAVI LTD et al.)
 [I] CN108042176  (ENMAI SHANGHAI MEDICAL TECH CO LTD et al.) [I] 1-11 * abstract * * paragraphs [0314] - [0356]; figures 1-15 *
by applicantUS7300458
 US8940003
 US9039749
 US8066757
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.